Date published: 2026-5-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

Annexin A9 Inhibitors

Annexin A9 inhibitors are a class of compounds that are not defined by a specific chemical structure but by their ability to interfere with the function or interaction of Annexin A9 with other cellular components. The inhibitors listed are chemicals that can modulate cellular processes such as calcium signaling, membrane dynamics, and cell signaling pathways, all of which are important for the proper functioning of Annexin A9.

Annexin A9 inhibitors are calcium chelators that sequester free calcium ions, thus potentially disrupting the calcium-dependent binding of Annexin A9 to phospholipid membranes. The precise membrane association of Annexin A9 is critical for its function, and alterations in membrane phospholipids through inhibitors can lead to a functional inhibition of Annexin A9 by changing its lipid environment. Furthermore, inhibitors can indirectly affect Annexin A9 by altering the signaling pathways it is involved in. These inhibitors target various enzymes and receptors that are upstream of Annexin A9, thus altering its activation state or its ability to interact with other proteins. Lastly, inhibitors that affect the membrane composition and integrity can also be considered indirect inhibitors. In summary, the chemical class of Annexin A9 inhibitors encompasses a variety of compounds that, by different mechanisms, all converge on the modulation of Annexin A9's activity or its interactions with cellular components.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

BAPTA/AM

126150-97-8sc-202488
sc-202488A
25 mg
100 mg
$138.00
$458.00
61
(2)

A cell-permeable calcium chelator that can disrupt calcium-dependent processes involving Annexin A9.

EGTA

67-42-5sc-3593
sc-3593A
sc-3593B
sc-3593C
sc-3593D
1 g
10 g
100 g
250 g
1 kg
$21.00
$65.00
$120.00
$251.00
$815.00
23
(1)

A calcium chelator that, like BAPTA-AM, can interfere with calcium-dependent activities of Annexin A9.

Wortmannin

19545-26-7sc-3505
sc-3505A
sc-3505B
1 mg
5 mg
20 mg
$67.00
$223.00
$425.00
97
(3)

A PI3K inhibitor that can alter downstream signaling pathways, potentially influencing Annexin A9's role.

Nifedipine

21829-25-4sc-3589
sc-3589A
1 g
5 g
$59.00
$173.00
15
(1)

A calcium channel blocker that may reduce calcium levels, thereby affecting Annexin A9's function.

Propranolol

525-66-6sc-507425
100 mg
$180.00
(0)

A non-selective beta-blocker that can influence signaling pathways, potentially altering Annexin A9 activity.

Genistein

446-72-0sc-3515
sc-3515A
sc-3515B
sc-3515C
sc-3515D
sc-3515E
sc-3515F
100 mg
500 mg
1 g
5 g
10 g
25 g
100 g
$45.00
$164.00
$200.00
$402.00
$575.00
$981.00
$2031.00
46
(1)

A tyrosine kinase inhibitor that can modify cell signaling pathways, possibly affecting Annexin A9.

Neomycin sulfate

1405-10-3sc-3573
sc-3573A
1 g
5 g
$27.00
$35.00
20
(5)

An aminoglycoside antibiotic that can bind to phospholipids, potentially disrupting Annexin A9 interactions.

2-Hydroxypropyl-β-cyclodextrin

128446-35-5sc-203461
sc-203461B
sc-203461C
sc-203461A
1 g
100 g
500 g
5 g
$53.00
$620.00
$1989.00
$133.00
8
(1)

A compound that extracts cholesterol from membranes, possibly affecting the lipid environment of Annexin A9